radium bromatum + apis mellifica

Radium bromatum + apis mellifica is a homeopathic combination treatment evaluated for the prevention and management of acute radiodermatitis in patients undergoing radiotherapy for breast cancer. The preparation consists of highly diluted radium bromide (radium bromatum) and honeybee extract (apis mellifica), typically formulated as oral pills or globules. In homeopathic practice, radium bromatum is indicated for skin conditions resulting from radiation exposure, while apis mellifica is used to address inflammatory symptoms such as edema, erythema, and stinging pain. The combination has been investigated in a Phase III clinical trial (NCT03753776) to assess its efficacy in reducing the severity of radiation-induced skin toxicity compared to placebo. As a homeopathic product, it operates on the principle of "like cures like" and has not been evaluated by the FDA for safety or efficacy.

Other names

radium bromide + honeybee